News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
dreamgenics-turns-8
DREAMgenics turns 8
Algenex and FATRO sign commercial license agreement for development of a second CrisBio -based vaccine
Algenex and FATRO sign commercial license agreement for development of a second CrisBio -based vaccine
Agreement strengthens collaboration between the companies following submission of the first dossier…
Partners - Algenex
ZYMVOLteam
European Commission awards ZYMVOL Biomodeling with H2020 SME Instrument Phase II (1,3 M€)
It´s for the project “UNLOCK-EDD: UNLOCK next generation computer guided Enzyme Discovery &…
Partners - Zymvol Biomodeling
analista-bioinformatico-dreamgenics
Meet Claudia García, new Bioinformatics Analyst at DREAMgenics
One of our goals is to count on the best professionals in order to offer excellence in our services…
Bayer Animal Health and VLPbio sign global collaboration agreement
Bayer Animal Health and VLPbio sign global collaboration agreement
Bayer Animal Health to strengthen its technology portfolio for biological 
bayer
Bayer Animal Health and VLPbio sign global collaboration agreement
Bayer Animal Health GmbH and VLPbio - The Vaccines Company S.L. have signed a global collaboration…
Partners - VLP Bio
First Algenex CrisBio®-based vaccine submitted to European Medicines Agency
First Algenex CrisBio®-based vaccine submitted to European Medicines Agency
Potential approval would validate the use of Algenex’ CrisBio® technology for the manufacture of…
Partners - Algenex
DREAMgenics estará en BIO-Europe 2019
Meet us at BIO-Europe 2019
The 25th anniversary of BIO-Europe takes place in Hamburg on November 11-13
VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan
VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan
VIVEbiotech will now have 600 square meters of clean rooms with 8 nanobioreactors and two large…
Partners - VIVEbiotech